No evidence of association was observed for HLA-DQA1*05 (OR 1.29, 95% CI 0.98–1.71, P = 0.07), which has previously been reported to be associated with ADA against TNF inhibitors in a population with IBD (12). Here, HLA-DQA1 is linked to inflammatory bowel disease.